247 related articles for article (PubMed ID: 199262)
61. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
Hidaka H; Asano T; Shimamoto T
Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
[TBL] [Abstract][Full Text] [Related]
62. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
63. Properties of adenylate cyclase and cyclic nucleotide phosphodiesterase in hamster isolated capillary preparations.
Nemecek GM
Biochim Biophys Acta; 1980 Mar; 628(2):125-35. PubMed ID: 6244001
[TBL] [Abstract][Full Text] [Related]
64. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
Rybalkin SD; Kurennaia GS; Sobolev AS
Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
[TBL] [Abstract][Full Text] [Related]
65. Partial purification and characterization of cyclic nucleotide phosphodiesterases from human bronchial tissue.
Bergstrand H; Lundquist B
Mol Cell Biochem; 1978 Oct; 21(1):9-15. PubMed ID: 215899
[TBL] [Abstract][Full Text] [Related]
66. Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.
Law J; Fumagalli A; Schein PS; Rahman A
Life Sci; 1985 Feb; 36(6):589-99. PubMed ID: 2982070
[TBL] [Abstract][Full Text] [Related]
67. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
Erneux C; Van Sande J; Dumont JE; Boeynaems JM
Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
[TBL] [Abstract][Full Text] [Related]
68. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
69. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
70. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
Nagasaka A; Hidaka H
J Clin Endocrinol Metab; 1980 Apr; 50(4):726-33. PubMed ID: 6245100
[TBL] [Abstract][Full Text] [Related]
71. Stimulation of hamster adipocyte cyclic 3':5'-nucleotide phosphodiesterase activity by ionophore A23187 and calcium.
Nemecek GM
J Cyclic Nucleotide Res; 1978 Aug; 4(4):299-309. PubMed ID: 214467
[TBL] [Abstract][Full Text] [Related]
72. Cyclic nucleotide phosphodiesterase activities in rat erythrocytes.
Téllez-Iñón MT; Torres HN
Mol Cell Biochem; 1982 Apr; 43(3):161-6. PubMed ID: 6283333
[TBL] [Abstract][Full Text] [Related]
73. Characterization of a rat liver cyclic GMP-activated phosphodiesterase by chromatography on hexyl-agarose. Inhibition of phosphodiesterase activity by hexyl-agarose.
Couchie D; Erneux C; Dumont JE
Biochem J; 1981 Nov; 199(2):441-6. PubMed ID: 6280669
[TBL] [Abstract][Full Text] [Related]
74. Selective inhibition of cyclic AMP phosphodiesterase from various human tissues by milrinone, a potent cardiac bipyridine.
Ito M; Tanaka T; Saitoh M; Masuoka H; Nakano T; Hidaka H
Biochem Pharmacol; 1988 May; 37(10):2041-4. PubMed ID: 2837222
[TBL] [Abstract][Full Text] [Related]
75. Identification and characterization of cyclic nucleotide phosphodiesterases.
Purcell EB; Tamayo R
Methods Mol Biol; 2013; 1016():235-43. PubMed ID: 23681583
[TBL] [Abstract][Full Text] [Related]
76. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.
Burns F; Rodger IW; Pyne NJ
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):487-91. PubMed ID: 1315515
[TBL] [Abstract][Full Text] [Related]
77. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
78. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
79. Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland.
Vale MR; Baker RV; Hope DB
J Neurochem; 1984 Feb; 42(2):377-83. PubMed ID: 6319599
[TBL] [Abstract][Full Text] [Related]
80. Cyclic nucleotide phosphodiesterase activity in bovine brain coated vesicles.
Silva WI; Schook W; Mittag TW; Puszkin S
J Neurochem; 1986 Apr; 46(4):1263-71. PubMed ID: 2869110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
